Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

206 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma.
Thylén A, Hjerpe A, Martensson G. Thylén A, et al. Among authors: hjerpe a. Cancer. 2001 Sep 1;92(5):1224-30. doi: 10.1002/1097-0142(20010901)92:5<1224::aid-cncr1441>3.0.co;2-u. Cancer. 2001. PMID: 11571736
Presence of simian virus 40 (SV40) is not frequent in Swedish malignant mesotheliomas.
Priftakis P, Bogdanovic G, Hjerpe A, Dalianis T. Priftakis P, et al. Among authors: hjerpe a. Anticancer Res. 2002 May-Jun;22(3):1357-60. Anticancer Res. 2002. PMID: 12168811
Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells.
Dobra K, Nurminen M, Hjerpe A. Dobra K, et al. Among authors: hjerpe a. Anticancer Res. 2003 May-Jun;23(3B):2435-44. Anticancer Res. 2003. PMID: 12894525
The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods.
Martensson G, Thylen A, Lindquist U, Hjerpe A. Martensson G, et al. Among authors: hjerpe a. Cancer. 1994 Mar 1;73(5):1406-10. doi: 10.1002/1097-0142(19940301)73:5<1406::aid-cncr2820730515>3.0.co;2-i. Cancer. 1994. PMID: 8111707 Clinical Trial.
Immunohistochemical differences between hyaluronan- and non-hyaluronan-producing malignant mesothelioma.
Thylén A, Levin-Jacobsen AM, Hjerpe A, Martensson G. Thylén A, et al. Among authors: hjerpe a. Eur Respir J. 1997 Feb;10(2):404-8. doi: 10.1183/09031936.97.10020404. Eur Respir J. 1997. PMID: 9042640
Carcinoembryonic antigen-like reactivity in malignant mesothelioma. A comparison between different commercially available antibodies.
Dejmek A, Hjerpe A. Dejmek A, et al. Among authors: hjerpe a. Cancer. 1994 Jan 15;73(2):464-9. doi: 10.1002/1097-0142(19940115)73:2<464::aid-cncr2820730235>3.0.co;2-#. Cancer. 1994. PMID: 8293414 Clinical Trial.
Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis.
Dejmek A, Hjerpe A. Dejmek A, et al. Among authors: hjerpe a. Cytopathology. 2000 Feb;11(1):8-17. doi: 10.1046/j.1365-2303.2000.00211.x. Cytopathology. 2000. PMID: 10714371
Human papillomavirus 'reflex' testing as a screening method in cases of minor cytological abnormalities.
Fröberg M, Johansson B, Hjerpe A, Andersson S. Fröberg M, et al. Among authors: hjerpe a. Br J Cancer. 2008 Aug 19;99(4):563-8. doi: 10.1038/sj.bjc.6604504. Br J Cancer. 2008. PMID: 18682715 Free PMC article.
Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.
Andersson S, Wallin KL, Hellström AC, Morrison LE, Hjerpe A, Auer G, Ried T, Larsson C, Heselmeyer-Haddad K. Andersson S, et al. Among authors: hjerpe a. Br J Cancer. 2006 Aug 7;95(3):331-8. doi: 10.1038/sj.bjc.6603253. Epub 2006 Jul 18. Br J Cancer. 2006. PMID: 16847471 Free PMC article.
A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears.
Chua KL, Wiklund F, Lenner P, Angström T, Hallmans G, Bergman F, Sapp M, Schiller J, Wadell G, Hjerpe A, Dillner J. Chua KL, et al. Among authors: hjerpe a. Int J Cancer. 1996 Sep 27;68(1):54-9. doi: 10.1002/(SICI)1097-0215(19960927)68:1<54::AID-IJC11>3.0.CO;2-6. Int J Cancer. 1996. PMID: 8895541
206 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback